KLH-2109
KLH-2109 is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Clinical Study of KLH-2109 in Patients With Endometriosis
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
Clinical Trials (7)
A Clinical Study of KLH-2109 in Patients With Endometriosis
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis
A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7